FAAH selectively influences placebo effects. - Wikidata - wikimedia - TriplyDB

FAAH selectively influences placebo effects.

FAAH selectively influences placebo effects.

http://www.wikidata.org/entity/Q34461780

about

Placebo, nocebo, and neuropathic pain Catechol-O-methyltransferase Val158Met polymorphism is associated with somatosensory amplification and nocebo responses Understanding placebo and nocebo responses for pain management.Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures Molecular mechanisms of placebo responses in humans.Placebo analgesia: understanding the mechanisms.Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response.Vasopressin Boosts Placebo Analgesic Effects in Women: A Randomized Trial Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression.Nonpharmacological Interventions in Targeting Pain-Related Brain Plasticity The placebo effect: From concepts to genes.Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes.Nocebo vs. placebo: the challenges of trial design in analgesia research.Genetics and the placebo effect: the placebome.Role of placebo effects in pain and neuropsychiatric disorders.Mechanisms of the placebo effect in pain and psychiatric disorders.Transmission pathways and mediators as the basis for clinical pharmacology of pain.Placebo-related effects: a meta-narrative review of conceptualization, mechanisms and their relevance in rheumatology.Placebo response in pain, fatigue, and performance: Possible implications for neuromuscular disorders.Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition.Mechanisms of placebo analgesia: A dual-process model informed by insights from cross-species comparisons.Severity of alcohol dependence is associated with the fatty acid amide hydrolase Pro129Thr missense variant.Genome-wide association studies of placebo and duloxetine response in major depressive disorder.Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.Creating placebo responders and nonresponders in the laboratory: boons and banes.

P2860

Q28072351-144AEF01-922E-4930-B019-6918B06CD425 Q28542991-AEFD1306-F0F7-4627-9280-AA470D3FF382 Q34081833-D305260F-4D53-47E1-9BFB-3D7A12DEFA04 Q35089406-8D08B783-5A8B-44EC-A07E-2BFA2918027B Q35214124-554338E2-0436-47BA-B8E2-5D3340498108 Q35297961-1A1DCFE0-E069-462E-AABD-777E5BA93D8F Q36382450-E2B44C58-25D9-42F7-8D95-EC5B3A50DE5F Q36540812-7260F5DE-3E26-4B73-ABEE-9BCD63B61648 Q36593892-A96F46AB-64A2-412A-87FE-FD1969D30C56 Q37680974-1F99CB08-A23F-4C2D-9654-BFE763D946F8 Q37723087-E3EE4333-5572-4AA9-A3D5-9C66E930FE9A Q38283173-021A1B85-69A2-4523-AC06-974E250183AC Q38351533-A32025DB-A526-4754-BC60-A724023644AE Q38425277-4911AD26-4EBA-4936-A5B1-1DE0B5E4A0D0 Q38673105-A3E10892-997B-47B5-91DF-22EFC5B861ED Q38784077-74E66349-9EBB-4A6F-A360-4A2EAB839506 Q38870522-4B218E0A-5D89-4654-A12B-CC881F1B9679 Q38914498-807915A6-58DE-4C1C-81BC-5E9418BD1506 Q38935410-8B5C382F-1ABD-497B-A466-CBC3AC9883DB Q40066269-0110DB9F-B292-4A43-B2F7-345F8B1F03F1 Q43075563-6FFC2206-9CEA-4DB2-8B71-51F3163F069A Q46413281-930E7E93-2327-48D4-B21C-CBE22DD77EC5 Q47671240-8F23165A-4104-4B3C-A422-E044DF6DC3FF Q47958585-0BFF6742-D321-47BB-B706-AB0A5634FF3B Q50653849-2249D90D-C1DE-4B75-8A8C-12D6331AB883

P2860

FAAH selectively influences placebo effects.

http://www.wikidata.org/entity/Q34461780

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

FAAH selectively influences placebo effects.

@ast

FAAH selectively influences placebo effects.

@en

FAAH selectively influences placebo effects.

@nl

type

label

FAAH selectively influences placebo effects.

@ast

FAAH selectively influences placebo effects.

@en

FAAH selectively influences placebo effects.

@nl

prefLabel

FAAH selectively influences placebo effects.

@ast

FAAH selectively influences placebo effects.

@en

FAAH selectively influences placebo effects.

@nl

P1433

Q34461780-A484FEF1-512C-4C71-AA45-12A2B447AC40

P1476

Q34461780-6B0518A8-4C15-4A78-A04A-376594CBB791

P2093

Q34461780-7133DE9F-B6CB-466E-B119-A3364DE9AA9B

Q34461780-82D157AB-6E9E-4CDE-AF20-AB998EB8CBCF

Q34461780-9F649747-C1C7-4D79-B5B2-B24061E7750E

Q34461780-B5AE1DBD-D606-473E-B4C7-4ED2C3B6C847

Q34461780-F7E477DE-266D-4A06-B5BD-3A5A5A90CF83

P2860

Q34461780-18839F18-9190-4F52-A10F-C176BF29C9E5

Q34461780-1A81C208-5659-4AD0-B8B3-6E505566F7C7

Q34461780-1C047FAD-4FD6-4B8B-908D-038AA3B6E185

Q34461780-21B06D9D-3243-4CDF-8DD4-7BF9173DDAC1

Q34461780-2595ACD6-B6F4-44F4-9F56-19F691E7DE30

Q34461780-26F8077B-CB80-4F32-97D2-2567A8478663

Q34461780-37862EE7-C6D2-4AE0-B0C0-0F49279C46FF

Q34461780-39697B9D-B1EB-4326-9051-0DDF8DB6C1B8

Q34461780-401AC4A7-77CD-44D5-9D26-25283FD905B7

Q34461780-414CCF61-814F-496A-ADE9-050127DDEF5F

P2888

Q34461780-BE7F3207-DFBB-4E77-9EE7-5F136FE93F6F

P304

Q34461780-A937A313-EFAF-4C09-97E5-69525BAFCCD3

P31

Q34461780-13444763-E6A5-4063-AE3A-83AD861A6BCA

P356

Q34461780-BC2B8777-1048-4928-8699-0FA8A18C39F8

P407

Q34461780-3A095176-B2F4-455B-BC5D-21EAFDF31F47

P433

Q34461780-B5C2D60C-F52A-4886-B6B7-0272DE3C449F

P478

Q34461780-C54473AC-F19D-4D37-8E8E-45F4752A3E50

P50

Q34461780-E06BC710-1287-4685-A183-C1BE15A796DC

P577

Q34461780-4F733A53-4575-491E-BA7E-893692D07A47

P5875

Q34461780-A8348795-C6E8-4947-83D1-20775E967372

P698

Q34461780-36EB4236-49F4-4ABD-8B56-9BED4DA20FE0

P921

Q34461780-C12DC817-63EE-42A8-90A6-F084E5159128

P932

Q34461780-A70A8889-D259-4B21-90AD-A50807F596A8

P356

P1433

Molecular Psychiatry

P1476

FAAH selectively influences placebo effects.

@en

P2093

C Hodgkinson

http://www.w3.org/2001/XMLSchema#string

C S Stohler

http://www.w3.org/2001/XMLSchema#string

J K Zubieta

http://www.w3.org/2001/XMLSchema#string

M Martínez-Jauand

http://www.w3.org/2001/XMLSchema#string

M Peciña

http://www.w3.org/2001/XMLSchema#string

P2860

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction

Development and validation of brief measures of positive and negative affect: the PANAS scales

Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase.

Role of μ-opioid system in the formation of memory of placebo responses.

Endocannabinoid signaling in the brain.

Placebo effects mediated by endogenous opioid activity on mu-opioid receptors.

Profile of Mood States: the factors and their physiological correlates.

Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses.

Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives.

P2888

P304

385-391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MP.2013.124

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256665329

http://www.w3.org/2001/XMLSchema#string

P698

24042479

http://www.w3.org/2001/XMLSchema#string

P921

P932

4222079

http://www.w3.org/2001/XMLSchema#string